Summary
Streptococcus suis causes septicaemia and meningitis in pigs and occasionally in humans. A major galactose-inhibitable adhesin recognizing the blood group P -related disaccharide Galαl–4Ga1β1-present in the GbO3 glycolipid was identified in S. suis. Two variant adhesins, inhibitable by galactose and N-acetylgalactosamine (type PN) or galactose only (type PO) both preferred the disaccharide in terminal position. The hydrogen bonding patterns were determined using deoxy and other derivatives of the receptor disaccharide, and were compared to that of E. coli PapG396 adhesin. The essential hydroxyls were the HO-4’, HO-6’, HO-2 and HO-3 hydroxyls; type PO adhesin also weakly interacted with HO-6 and HO-3’. The mechanism differed from that of E. coli which binds to a cluster of five hydroxyls, HO-6, HO-2’, HO-3’, HO-4’ and HO-6’. The purified adhesin had a molecular weight of 18 kDa and an isoelectric point of 6.4. The agglutination of latex-bound purified adhesin was inhibited by the same inhibitors as agglutination with whole bacteria. The adhesin was detected by immunoblot analysis in all 23 S. suis strains examined representing different serotypes, was highly immunogenic and showed opsonizing activity. This represents the first example of the comparison of the saccharide receptor hydrogen bondings of two bacteria of different origin and shows that the same saccharide may be recognised by two different mechanisms. As a potential virulence factor present in different serotypes the adhesin represents a potential vaccine against S. suis infections.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
J.P. Arends and H.C. Zanen, Meningitis caused by Streptococcus suis in humans, Rev. Infect. Dis. 10:131–137 (1988).
E.B. Beachey, Bacterial adherence: Adhesin-receptor interactions mediating the attachment of bacteria to mucosal surfaces, J. Infect. Dis. 143:325–345 (1981).
M. Cantin, J. Harel, R. Higgins, and M. Gottschalk, Antimicrobial resistance patterns and plasmid profiles of Streptococcus suis isolates, J. Vet. Diagn. Invest. 4:170–174 (1992).
A.P. Corfield, H. Higa, J.C. Paulson, and R. Schauer, The specificity of viral and bacterial sialidases for alpha(2–3)- and alpha(2–6)-linked sialic acids in glycoproteins, Biochim. Biophys. Acta 744:121–126 (1983).
J.P. Duguid, S. Clegg, and M.I. Wilson, The fimbrial and non-fimbrial haemagglutinins of Escherichia coli, J. Med Microbiol 12:213–227(1979).
J. Finne, Polysialic acid - a glycoprotein carbohydrate involved in neural adhesion and bacterial meningitis, Trends Biochem. Sci. 10:129–132 (1985).
M.N. Fukuda, M. Fukuda, and S. Hakomori, Cell surface modification by endo-beta-galactosidase. Change of blood group activities and release of oligosaccharides from glycoproteins and glycosphingolipids of human erythrocytes, J. Biol Chem. 254:5458–5465 (1979).
S. Haataja, K. Tikkanen, J. Liukkonen, C. François-Gerard, and J. Finne, Characterization of a novel bacterial adhesion specificity of Streptococcus suis recognizing blood group P receptor oligosaccharides, J. Biol Chem. 268:4311–4317 (1993).
S. Haataja, K. Tikkanen, U. Nilsson, G. Magnusson, K.-A. Karlsson, and J. Finne, Oligosaccharide-receptor interaction of the Galα l–4Gal binding adhesin of Streptococcus suis. Combining site architecture and characterization of two variant adhesin specificities, J. Biol Chem. 269:27466–27472 (1994).
R. Higgins, M. Gottschalk, M. Boudreau, A. Lebrun, and J. Henrichsen, Description of six new capsular types (29–34) of Streptococcus suis, J. Vet. Diagn. Invest. 7:405–406 (1995).
K.-A. Karlsson, Animal glycosphingolipids as membrane attachment sites for bacteria, Annu. Rev. Biochem. 58:309–350(1989).
J. Kihlberg, S.J. Hultgren, S. Normark, and G. Magnusson, Probing of the combining site of the PapG adhesin of uropathogenic Escherichia coli bacteria by synthetic analogues of galabiose, J. Am. Chem. Soc. 111:6364–6368 (1989).
T.K. Korhonen and J. Finne, Agglutination assays for detecting bacterial binding specificities, in: “Enterobacterial surface antigens: methods for molecular characterization”, T.K. Korhonen et al., eds., Elsevier Science Publishers, Amsterdam, pp. 301–313 (1985).
J. Liukkonen, S. Haataja, K. Tikkanen, S. Keim, and J. Finne, Identification of N-acetylneuraminyl α2→3 poly- N-acetyllactosamine glycans as the receptors of sialic acid-binding Streptococcus suis strains, J. Biol Chem. 267:21105–21111 (1992).
R.Y. Reams, L.T. Glickman, D.D. Harrington, T.L. Bowersock, and H.L. Thacker, Streptococcus suis infection in swine: a retrospective study of256 cases. Part I. Epidemiologic factors and antibiotic susceptibility patterns, J. Vet. Diagn. Invest. 5:363–367 (1993).
N. Sharon, Bacterial lectins, cell-cell recognition and infectious disease, FEBS Lett. 217:145–157 (1987).
K. Tikkanen, S. Haataja, C. François-Gérard, and J. Finne, Purification of a galactosyl-α1–4-galactose-binding adhesin from the gram-positive meningitis-associated bacterium Streptococcus suis, J. Biol Chem. 270:28874–28878 (1995).
A.R. Tunkel and W.M. Scheid, Pathogenesis and pathophysiology of bacterial meningitis, Annu. Rev. Med. 44:103–120(1993).
C.H. Twort, Group R streptococcal meningitis (Streptococcus suis type II): a new industrial disease? Br. Med J. Clin. Res. Ed. 282:523–524 (1981).
V. Väisänen-Rhen, T.K. Korhonen, and J. Finne, Novel cell-binding activity specific for N-acetyl-D-glu- cosamine in an Escherichia coli strain, FEBS Lett. 159:233–236 (1983).
R.S. Windsor, Meningitis in pigs caused by Streptococcus suis type II, Vet. Rec. 101:378–379 (1977).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Plenum Press, New York
About this chapter
Cite this chapter
Haataja, S., Tikkanen, K., Hytönen, J., Finne, J. (1996). The GALα1–4GAL-Binding Adhesin of Streptococcus Suis, A Gram-Positive Meningitis-Associated Bacterium. In: Kahane, I., Ofek, I. (eds) Toward Anti-Adhesion Therapy for Microbial Diseases. Advances in Experimental Medicine and Biology, vol 408. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0415-9_3
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0415-9_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-8042-9
Online ISBN: 978-1-4613-0415-9
eBook Packages: Springer Book Archive